Grifols Sa Adr (GRFS)

Mar 20, 2025

6 undervalued stocks with low beta - Morningstar

Mar 20, 2025

Mar 10, 2025

Deutsche Bank raises Grifols SA price target to EUR11.00 - Investing.com India

Mar 10, 2025

Feb 27, 2025

Grifols: Looking At The Longer-Term 2025-2027 Upside After No Sale (GRFS) - Seeking Alpha

Feb 27, 2025

Feb 06, 2025

Get in on Grifols SA ADR’s (GRFS) buy-in window today! - SETE News

Feb 06, 2025

Feb 06, 2025

Wall Street analysts’ outlook for Douglas Elliman Inc (DOUG) - SETE News

Feb 06, 2025

Feb 04, 2025

Financial Metrics Exploration: Understanding Accuray Inc (ARAY) Through Ratios - The Dwinnex

Feb 04, 2025

Feb 04, 2025

Financial Fitness Check: Examining Mannkind Corp (MNKD)’s Key Ratios - The Dwinnex

Feb 04, 2025

Feb 03, 2025

Orphan Designated Drugs Market Analysis: Key Trends, Players and Forecasts for Future Growth - GlobeNewswire Inc.

Feb 03, 2025

Nov 29, 2024

Grifols: More Attractive Than In A Very Long Time (NASDAQ:GRFS) - Seeking Alpha

Nov 29, 2024

Nov 28, 2024

Grifols Stock Declines After Brookfield Drops Buyout Offer - Barchart

Nov 28, 2024

Nov 28, 2024

BRF S.A. goes ex dividend tomorrow - MSN

Nov 28, 2024

Nov 27, 2024

Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols - BNN Bloomberg

Nov 27, 2024

Nov 20, 2024

Grifols slips as board rebuffs Brookfield’s $6.8B offer (update) - MSN

Nov 20, 2024

Nov 20, 2024

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8% - MSN

Nov 20, 2024

Nov 20, 2024

Grifols falls amid potential Moody's downgrade, new short report - MSN

Nov 20, 2024

Nov 19, 2024

Grifols stock slips as Brookfield offer rebuffed (GRFS:NASDAQ) - Seeking Alpha

Nov 19, 2024

Oct 16, 2024

Is it possible to buy Grifols SA ADR(GRFS) shares at a good price now? - US Post News

Oct 16, 2024

Oct 03, 2024

Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down (NASDAQ:GRFS) - Seeking Alpha

Oct 03, 2024

Sep 25, 2024

Orange To Delist From NYSE To Reduce Financial Burdens - Yahoo Finance

Sep 25, 2024

Sep 19, 2024

Ratio Review: Analyzing Grifols SA ADR (GRFS)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 19, 2024

Sep 16, 2024

Mexico Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research

Sep 16, 2024

Sep 08, 2024

UK Intravenous Immunoglobulin Market Size & Outlook, 2030 - Grand View Research

Sep 08, 2024

Sep 05, 2024

Grifols Class B stock falls as Brookfield reportedly seeks lower price - MSN

Sep 05, 2024

Sep 03, 2024

The UAE Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research

Sep 03, 2024

Aug 22, 2024

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday - Yahoo Finance

Aug 22, 2024

Aug 21, 2024

Grifols shares up on potential takeover by Brookfield - Investing.com

Aug 21, 2024

Aug 10, 2024

China Intravenous Immunoglobulin Market Size & Outlook, 2030 - Grand View Research

Aug 10, 2024

Aug 09, 2024

India Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research

Aug 09, 2024

Jul 16, 2024

Grifols: Going Private? Brookfield On The Scene (OTCMKTS:GIFLF) - Seeking Alpha

Jul 16, 2024

Jun 10, 2024

Grifols, S.A. (BME:GRF) most popular amongst retail investors who own 45% of the shares, institutions hold 35% - Simply Wall St

Jun 10, 2024

Apr 19, 2024

Grifols 2023 Annual Report on Form 20-F filed with the SEC - PR Newswire

Apr 19, 2024

Mar 27, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A.GRFS - PR Newswire

Mar 27, 2024

Feb 17, 2024

AMBAR, an Encouraging Alzheimer's Trial That Raises Questions - Frontiers

Feb 17, 2024

Feb 16, 2024

The 10 Most-Bought and Most-Sold European Stocks - Morningstar

Feb 16, 2024

Jan 11, 2024

Grifols sees China stake sale going ahead despite Gotham City report - Reuters

Jan 11, 2024

Jan 09, 2024

BreakingviewsShort attack intensifies Grifols’ health problem - Reuters

Jan 09, 2024

Nov 16, 2023

Grifols launches new solution to facilitate pre-transfusion compatibility testing in multiple myeloma patients - PR Newswire UK

Nov 16, 2023

Apr 18, 2023

Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023 - PR Newswire

Apr 18, 2023

Nov 08, 2022

Novo Nordisk A/s Dividend History & Dividend Yield 2024 - INDmoney

Nov 08, 2022

Sep 07, 2022

Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada - PR Newswire

Sep 07, 2022

Jul 21, 2022

8 Newly Undervalued 5-Star Stocks - Morningstar

Jul 21, 2022

Apr 29, 2022

Grifols 2021 Annual Report on Form 20-F filed with the SEC on April 29, 2022 - PR Newswire

Apr 29, 2022

Jun 23, 2021

OZTA Stock Price and Chart — BER:OZTA - TradingView

Jun 23, 2021

Jul 04, 2019

Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies - PR Newswire

Jul 04, 2019

Jun 06, 2019

How International Is Your Foreign-Stock Fund? - Morningstar

Jun 06, 2019

Mar 29, 2018

Estimating The Fair Value Of Grifols SA. (BME:GRF) - Yahoo Finance

Mar 29, 2018

Aug 03, 2017

GRF Stock Price and Chart — BME:GRF - TradingView

Aug 03, 2017

Jan 04, 2017

Grifols SA Stock Price Today | BME: GRLS Live - Investing.com

Jan 04, 2017